MedsFacts.com




MedsFacts Meta-Analysis covering adverse side effect reports of LAMOTRIGINE patients who developed PHARMACEUTICAL PRODUCT COUNTERFEIT.



Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 2 individuals taking LAMOTRIGINE reported PHARMACEUTICAL PRODUCT COUNTERFEIT to the FDA. A total of 13265 LAMOTRIGINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

Topics covered: This page is designed to help you determine the relationship, if any, between LAMOTRIGINE and PHARMACEUTICAL PRODUCT COUNTERFEIT. In doing so, we compare LAMOTRIGINE with other drugs that cause PHARMACEUTICAL PRODUCT COUNTERFEIT, to help you evaluate whether or not LAMOTRIGINE causes PHARMACEUTICAL PRODUCT COUNTERFEIT. Likewise, this page shows the most highly-reported side effects of LAMOTRIGINE, so you can see if PHARMACEUTICAL PRODUCT COUNTERFEIT ranks among LAMOTRIGINE's most well-known side effects.

The Dashboard explained: The Dashboard first shows general Summary Statistics for LAMOTRIGINE and PHARMACEUTICAL PRODUCT COUNTERFEIT, such as the raw number and percentage of patients in FDA reports who used LAMOTRIGINE and developed PHARMACEUTICAL PRODUCT COUNTERFEIT. Next, the Dashboard lists the most common reasons (indications) why LAMOTRIGINE was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of LAMOTRIGINE. This pie-chart summarizes, for all FDA reports covering LAMOTRIGINE, whether or not the treating physician felt LAMOTRIGINE (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering LAMOTRIGINE. You may click on any of these side effects to learn more about them, in general, or specifically for LAMOTRIGINE. Finally, we identify the drugs most widely associated with LAMOTRIGINE in FDA literature. You may also click on any of these drugs to view it's dashboard.

Dashboard view of our research literature concerning LAMOTRIGINE :

Summary Statistics
Reports of PHARMACEUTICAL PRODUCT COUNTERFEIT in patients taking LAMOTRIGINE: 2
Reports of any side effect developing while on LAMOTRIGINE : 13265
Percentage of LAMOTRIGINE patients where PHARMACEUTICAL PRODUCT COUNTERFEIT is a reported side effect: 0.015077271013946%

FDA reports of any drug causing PHARMACEUTICAL PRODUCT COUNTERFEIT : 292
Average percentage for all medicated patients where PHARMACEUTICAL PRODUCT COUNTERFEIT is reported as a complication: 0.0018300836291812%


Physician opinion on LAMOTRIGINE as adverse event culprit:

(* global)
Most common side effects for patients taking LAMOTRIGINE:
CONVULSION (1551 patients)
DRUG EXPOSURE DURING PREGNANCY (911 patients)
DRUG INTERACTION (765 patients)
DRUG INEFFECTIVE (744 patients)
RASH (638 patients)
PYREXIA (591 patients)
DIZZINESS (554 patients)
COMPLETED SUICIDE (525 patients)
SOMNOLENCE (504 patients)
VOMITING (499 patients)
DEPRESSION (495 patients)
NAUSEA (493 patients)
HEADACHE (489 patients)
CONDITION AGGRAVATED (429 patients)
EPILEPSY (410 patients)
FATIGUE (409 patients)
GRAND MAL CONVULSION (402 patients)
PRODUCT SUBSTITUTION ISSUE (388 patients)
TREMOR (366 patients)
FALL (339 patients)
INSOMNIA (330 patients)
ANXIETY (329 patients)
CONFUSIONAL STATE (309 patients)
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (301 patients)
MATERNAL DRUGS AFFECTING FOETUS (301 patients)
STEVENS-JOHNSON SYNDROME (290 patients)
OVERDOSE (276 patients)
AGITATION (267 patients)
DYSPNOEA (266 patients)
MATERNAL EXPOSURE DURING PREGNANCY (264 patients)
DIARRHOEA (258 patients)
AGGRESSION (247 patients)
FEELING ABNORMAL (245 patients)
TOXICITY TO VARIOUS AGENTS (243 patients)
MALAISE (242 patients)
ASTHENIA (241 patients)
TACHYCARDIA (235 patients)
PAIN (231 patients)
BALANCE DISORDER (228 patients)
SUICIDE ATTEMPT (226 patients)
PLATELET COUNT DECREASED (223 patients)
VISION BLURRED (221 patients)
IRRITABILITY (220 patients)
DRUG TOXICITY (217 patients)
ABORTION SPONTANEOUS (215 patients)
CARDIAC ARREST (214 patients)
SUICIDAL IDEATION (211 patients)
PRURITUS (206 patients)
STATUS EPILEPTICUS (195 patients)
Most frequent diagnoses/indications for prescribing LAMOTRIGINE:
EPILEPSY ( 2366 patients )
BIPOLAR DISORDER ( 1043 patients )
CONVULSION ( 773 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 646 patients )
DRUG USE FOR UNKNOWN INDICATION ( 550 patients )
DEPRESSION ( 373 patients )
AFFECTIVE DISORDER ( 159 patients )
GRAND MAL CONVULSION ( 118 patients )
PARTIAL SEIZURES ( 116 patients )
BIPOLAR I DISORDER ( 107 patients )
BIPOLAR II DISORDER ( 82 patients )
DRUG EXPOSURE DURING PREGNANCY ( 80 patients )
SCHIZOPHRENIA ( 73 patients )
COMPLEX PARTIAL SEIZURES ( 67 patients )
MOOD SWINGS ( 56 patients )
MYOCLONIC EPILEPSY ( 49 patients )
PETIT MAL EPILEPSY ( 46 patients )
MAJOR DEPRESSION ( 45 patients )
ILL-DEFINED DISORDER ( 43 patients )
MOOD ALTERED ( 42 patients )
TEMPORAL LOBE EPILEPSY ( 42 patients )
SCHIZOAFFECTIVE DISORDER ( 39 patients )
MIGRAINE ( 36 patients )
BORDERLINE PERSONALITY DISORDER ( 33 patients )
PSYCHOTIC DISORDER ( 33 patients )
ANXIETY ( 31 patients )
INTENTIONAL OVERDOSE ( 30 patients )
NERVOUS SYSTEM DISORDER ( 24 patients )
SUICIDE ATTEMPT ( 22 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 22 patients )
INFANTILE SPASMS ( 20 patients )
MATERNAL EXPOSURE DURING PREGNANCY ( 18 patients )
CONVULSION PROPHYLAXIS ( 18 patients )
DEPRESSED MOOD ( 18 patients )
TRIGEMINAL NEURALGIA ( 17 patients )
MENTAL DISORDER ( 17 patients )
STATUS EPILEPTICUS ( 16 patients )
LENNOX-GASTAUT SYNDROME ( 16 patients )
POST-TRAUMATIC STRESS DISORDER ( 16 patients )
MANIA ( 15 patients )
IDIOPATHIC GENERALISED EPILEPSY ( 15 patients )
SIMPLE PARTIAL SEIZURES ( 13 patients )
POST-TRAUMATIC EPILEPSY ( 11 patients )
BACK PAIN ( 11 patients )
PAIN ( 11 patients )
OVERDOSE ( 10 patients )
ANTIDEPRESSANT THERAPY ( 10 patients )
DRUG THERAPY ( 9 patients )
HALLUCINATION ( 9 patients )
ABNORMAL BEHAVIOUR ( 8 patients )
MIGRAINE PROPHYLAXIS ( 8 patients )
POISONING DELIBERATE ( 8 patients )
FRONTAL LOBE EPILEPSY ( 7 patients )
SCHIZOPHRENIA, PARANOID TYPE ( 7 patients )
ACCIDENTAL OVERDOSE ( 6 patients )
TRAUMATIC BRAIN INJURY ( 6 patients )
MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION ( 6 patients )
SUICIDAL IDEATION ( 6 patients )
COMPLETED SUICIDE ( 6 patients )
ATTENTION DEFICIT/HYPERACTIVITY DISORDER ( 5 patients )
PANIC ATTACK ( 5 patients )
INTRACRANIAL INJURY ( 5 patients )
HEADACHE ( 5 patients )
DRUG EXPOSURE VIA BREAST MILK ( 4 patients )
CENTRAL NERVOUS SYSTEM LESION ( 4 patients )
IRRITABILITY ( 4 patients )
ANGER ( 4 patients )
PROPHYLAXIS ( 4 patients )
NEURALGIA ( 4 patients )


Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.





Copyright 2013 MedsFacts
info@medsfacts.com
Privacy Policy
Terms of use